Description
EO 14398 REQUIREMENT
Base award description: PET RADIOPHAMACEUTICALS
Modification chain · 8 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2023-10-02+$216,925= $216,925
- Mod P000012024-09-03+$22,250= $239,175
- Mod P000022024-09-24+$0= $239,175
- Mod P000032024-10-01+$211,210= $450,385
- Mod P000042025-02-24-$70,951= $379,434
- Mod P000052025-10-01+$0= $379,434
- Mod P000072025-10-01+$220,873= $600,307
- Mod P000082026-08-19+$0= $600,307
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2023-10-02 | +$216,925 | $216,925 | PET RADIOPHAMACEUTICALS |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-09-03 | +$22,250 | $239,175 | PET RADIOPHAMACEUTICALS INCREASE OY PRICING |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-09-24 | +$0 | $239,175 | DECREASE IN QUANTITY. |
| Mod P00003· EXERCISE AN OPTION | 2024-10-01 | +$211,210 | $450,385 | PET RADIOPHAMACEUTICALS (OY1) |
| Mod P00004· FUNDING ONLY ACTION | 2025-02-24 | −$70,951 | $379,434 | PET RADIOPHAMACEUTICALS (OY1) |
| Mod P00005· FUNDING ONLY ACTION | 2025-10-01 | +$0 | $379,434 | INCREASE PRICE PER PUBLIC LAW ON OPTION PERIOD 2 FOR PET RADIOPHAMACEUTICALS |
| Mod P00007· EXERCISE AN OPTION | 2025-10-01 | +$220,873 | $600,307 | PET RADIOPHAMACEUTICALS (OY2) |
| Mod P00008· OTHER ADMINISTRATIVE ACTION | 2026-08-19 | +$0 | $600,307 | EO 14398 REQUIREMENT |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI JV1AHJHGUGG3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25526N0392 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $357,066 | FY2026 |
| 36C25526N0245 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $1,172,834 | FY2026 |
| 36C24226N0463 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $624,017 | FY2026 |
| 36C24226N0388 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $830,796 | FY2026 |
| 36C24226D0040 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C25026P0310 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $347,000 | FY2026 |
Other recipients under 6505 from 261-NETWORK CONTRACT OFFICE 21 (36C261) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26126P1178 | OPTUM FRONTIER THERAPIES II, LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $58,374 | FY2026 |
| 36C26126P1102 | ENVIGO RMS LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $74,586 | FY2026 |
| 36C26126P0961 | 10X GENOMICS, INC. | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $34,600 | FY2026 |
| 36C26126P0997 | SIERRA RADIOPHARMACY LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $247,204 | FY2026 |
| 36C26126P1008 | OPTUM FRONTIER THERAPIES II, LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $58,374 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26124P0052_3600_-NONE-_-NONE- · retrieved 2026-09-26.